BioSpace News Archive

Drug Development

Pros and Cons of the Common Types of COVID-19 Tests

While COVID-19 tests have been crucial in identifying and tracking cases of infection and disease-related morbidity and mortality, they aren’t without their potential drawbacks.

October 14, 2020
·
5 min read
·
Brandon May
Career Advice

4 Things to Make Sure You Don’t Include on Your Resume

When a recruiter or hiring manager is scanning it, you want them to be able to immediately understand your strengths, experiences and why you’re the right fit for the open position.

October 14, 2020
·
2 min read
·
Laura Brothers
Testing and Analysis Services Market: North America to Dominate Global Market

Transparency Market Research has published a new report titled, ‘Testing and Analysis Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

October 14, 2020
·
7 min read
Oncology Companion Diagnostic Market | Economic Benefits Offered by the Assay to Shoot Up its Demand in the Market

Companion diagnostics are developed along with drugs so as to assist in the exclusion or selection of groups for the purpose of treating patients with a certain drug, based on biological characteristics of the selected pool of patients.

October 14, 2020
·
4 min read
Sleep Aids Market | High Prevalence of Sleep Disorders to Contribute toward Spiraling Demand in the Market

Sleep aids refer to those medical devices and drugs that are utilized in the diagnosis and treatment of various types of sleep disorders, including insomnia and sleep apnea.

October 14, 2020
·
3 min read
Electroporation Instruments Market: Progress in Gene Editing Techniques to Propel Market Growth

According to the report, the global electroporation instruments market was valued at ~US$ 126 Mn in 2019 and is projected to reach ~US$ 244 Mn by 2030, expanding at a CAGR of ~6% from 2020 to 2030.

October 14, 2020
·
5 min read
Drug Development

Aliqopa™ (copanlisib) in Combination With Rituximab Meets Primary Endpoint in Patients With Relapsed Indolent Non-Hodgkin’s Lymphoma

Phase III study CHRONOS-3 in patients with relapsed indolent Non-Hodgkin’s Lymphoma (iNHL) who have received one or more prior lines of rituximab-containing therapy meets primary endpoint of progression-free survival

October 14, 2020
·
12 min read
Drug Development

TLC Enrolls First Subject in Phase I Clinical Trial of Inhalable Anti-COVID-19 Program (TLC19)

TLC announced that the first subject has been enrolled in the Phase I clinical trial of TLC19 for treatment or prophylaxis of Coronavirus disease 2019.

October 14, 2020
·
4 min read
Genetown

Dyno Therapeutics Enters Collaboration and License Agreement With Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies

Collaboration combines Dyno’s AI-powered AAV vector capabilities with Roche and Spark Therapeutics’ leading-edge gene therapy capabilities

October 14, 2020
·
4 min read
BioMidwest

Louis Stokes Cleveland VA Medical Center Purchases ViewRay’s MRIdian Linac for MRI-Guided Radiation Therapy

MRIdian to Bring Benefits of MRI-Guided Radiation Therapy to Veterans Throughout Ohio and the Surrounding Region

October 14, 2020
·
4 min read